Plain-English translation of NCT06258447 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing CardiAMP cell therapy, a treatment that uses cells collected from your own bone marrow to potentially help your heart work better. Doctors will extract bone marrow cells, process them using a special system, and inject them directly into your heart muscle during a catheterization procedure. The goal is to see whether this treatment can safely improve heart function in people with ischemic heart failure.
Heart failure caused by previous heart attacks is a serious condition that limits how well the heart pumps blood to the body, and current treatments don't work well enough for everyone. Early research suggests that this bone marrow cell therapy might help repair damaged heart tissue and improve heart function, but it needs to be tested in a large, rigorous trial to prove it works safely and effectively.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to either receive the CardiAMP cell therapy treatment or a control procedure (diagnostic catheterization only). If you receive the treatment, doctors will perform a heart catheterization to access your heart, extract bone marrow from your hip bone, process the cells using the CardiAMP system, and inject them into your damaged heart tissue. All participants will have follow-up visits to monitor your heart function and overall health over time.
AI-generated summary from trial data · Jul 10, 2026 · Not medical advice
United States